BUZZ-C3.ai stock rises after Northland Capital upgrades rating
路透社2026/10/12 13:23October 12 - ** C3.ai (AI.N) shares rose 4.3% in pre-market trading, to $12.02
** Brokerage Northland Capital upgraded the enterprise AI software provider’s rating to “outperform”
** Northland Capital said that the company’s new product, C3 Code, is expected to help it win customers faster and drive stronger revenue growth
** The brokerage expects that as AI demand improves and more customers increase their investment, revenue growth will accelerate, supporting a stronger long-term growth outlook
** The target price was raised from $10 to $16, about a 39% premium over the previous session’s closing price
** As of the previous session’s close, the stock had declined 14.5% year-to-date
(To assist non-English speakers, Reuters automatically translates its reports into several other languages. Due to possible errors with automated translation or a lack of required context, Reuters does not guarantee the accuracy of the automated translation. Automated translations are provided for reader convenience only. Reuters is not liable for any harm or losses arising from use of the automated translation feature.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly
The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Kroger (KR.US) faces the largest layoffs in 143 years: cutting one-third of positions, more than 3,000 employees to be let go
Kroger has laid off 3,000 employees, accounting for more than one-third of its total workforce, marking the largest layoff in its 143-year history. The resources saved will be redirected towards price reductions and frontline operations.
RBA Minutes: Case for rates to act promptly to keep inflation expectations anchored
Crypto prices
More
